Hormonal
Regular moderate-intensity physical activity (≥30 min, ≥5 times/week) improves insulin sensitivity and glycemic control in adults with type 2 diabetes, potentially reducing medication needs.
Aim for 30 minutes of moderate activity, like brisk walking, at least five days a week. If you have physical limitations, consult a healthcare provider to create an individualized plan that fits your abilities. This helps manage blood sugar and may reduce the need for medication.
Appropriate use of diet and exercise can improve insulin sensitivity and glycemic control and decrease the need for oral medications or insulin (1,2).
Why this rating
The paper is an observational cross-sectional study (NHANES III) reporting prevalence, not a randomized controlled trial (RCT) measuring the causal effect of exercise on glycemic control.
Source
Diet and Exercise Among Adults With Type 2 Diabetes
Karin M. Nelson et al. · Diabetes Care · 2002
DOI 10.2337/diacare.25.10.1722
More from this paper
- Dietary adherence to national guidelines (≥5 servings of fruits/vegetables daily, <30% calories from fat, <10% from saturated fat) is suboptimal in the majority of adults with type 2 diabetes.Moderate
- Older adults (≥65 years) and Mexican Americans with type 2 diabetes are more likely to adhere to dietary guidelines (higher fruit/vegetable intake, lower saturated fat) compared to other demographic groups.Moderate
- Lower income, older age (≥65 years), and female gender are independently associated with physical inactivity in adults with type 2 diabetes.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →